Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH
World Journal of Urology · 2022-02 · 40 (2) · 483-487
DOI: 10.1007/s00345-021-03882-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Urology, online erschienen am 22.11.2021. Verfasst von Ahmed Mahmoud Hasan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Qena Faculty of Medicine, South Valley University, Qena, Egypt. drahmeduro20060@gmail.com. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Urinary Bladder Calculi. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This report presents the results of a randomized prospective study comparing synchronous transurethral cystolitholapaxy and transurethral resection of the prostate (TURP) with transurethral cystolitholapaxy plus medical treatment for benign prostatic hyperplasia (BPH) in patients with concomitant vesical stone(s) and BPH. PATIENTS AND METHODS: The study included 100 patients with bladder stone(s) < 2.5 cm associated with BPH. Eligible patients were divided randomly into two groups: group I (n = 50 patients) underwent simultaneous transurethral cystolitholapaxy and TURP, and group II (n = 50 patients) underwent transurethral cystolitholapaxy and received postoperative tamsulosin plus finasteride. RESULTS: The mean follow-up was 20.1 ± 5.3 months. No statistically significant differences were found between the 2 groups regarding the preoperative parameters (age, prostatic volume, bladder stone characteristics, prostate-specific antigen level, International Prostate Symptom Score, peak urinary flow rate, and post-void residual urine volume). Both groups experienced statistically significant postoperative improvement in IPSS, post-void residual (PVR) urine volume, and peak flow rate compared with the preoperative parameters (P < 0.001 for all parameters). However, patients in group 1 had a more pronounced improvement (P < 0.001 for all parameters). Thus, 15 patients in group 2 underwent TURP during follow-up. PVR urine and prostate volume predicted the failure of medical therapy and the need for TURP. CONCLUSION: Synchronous transurethral cystolitholapaxy and TURP revealed better results than transurethral cytolitholapaxy plus medical therapy. Cystolitholapaxy without TURP should not be indicated especially in patients with significant PVR urine volumes and larger prostates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Department, Qena Faculty of Medicine, South Valley University, Qena, Egypt. drahmeduro20060@gmail.com.
- Urology Department, Qena Faculty of Medicine, South Valley University, Qena, Egypt.
Zitieren
APA
Hasan, A. M., AbdelRazek, M., Ali, A. F., Alsaghier, O. M., Ahmed, A. A., & Alsaghier, G. A. (2022). Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH. World Journal of Urology, 40(2), 483-487. https://doi.org/10.1007/s00345-021-03882-4
Vancouver
Hasan AM, AbdelRazek M, Ali AF, Alsaghier OM, Ahmed AA, Alsaghier GA. Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH. World Journal of Urology. 2022;40(2):483-487. doi:10.1007/s00345-021-03882-4
BibTeX
@article{Hasan2022,
author = {Hasan, Ahmed Mahmoud and AbdelRazek, Mostafa and Ali, Atef Fathi and Alsaghier, Omar Mohamed and Ahmed, Ahmed Abdein and Alsaghier, Gamal Abdelhamid},
title = {Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH},
journal = {World Journal of Urology},
year = {2022},
volume = {40},
number = {2},
pages = {483--487},
doi = {10.1007/s00345-021-03882-4}
}
EUVIMED